Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

CSE:SONA - Post by User

Sona Nanotech Inc > Darn it, we have competition. :(

<< Previous

Bullboard Posts

Next >>

Comment by TheeRookon Aug 13, 2020 11:23am

144 Views

Post# 31403356

RE:RE:RE:RE:Darn it, we have competition. :(

No positive COVID-19 tests in NBA bubble for 3rd consecutive week

The NBA's bubble is still working.

The league released its latest results Wednesday for coronavirus tests performed on players participating in the restarted season at Walt Disney World, and the numbers are still perfect. Of the 343 players tested since results were last announced July 29, none has been confirmed positive.

That means no player has tested positive since entering the so-called bubble three weeks ago. There were two players who tested positive on arrival at Disney, with neither of those making it out of quarantine and potentially exposing anyone inside the bubble.

https://www.cbc.ca/sports/basketball/nba/nba-covid-19-testing-1.5675396

TheeRook wrote:

SWISH

To determine if SalivaDirect can accurately detect asymptomatic cases, our team at the Yale School of Public Health are partnering with the National Basketball Association and National Basketball Players Association, as they look to continue playing while ensuring the health of players and staff. The partnership, the Surveillance with Improved Screening and Health (SWISH) Study involves side-by-side testing of samples collected from players and staff using a standard nasal/oral test for SARS-CoV-2 and SalivaDirect. We’ll compare the outcomes of each test, and post the results at the study conclusion (likely late August).